Search clinical trials for: Xpert® HCV Viral test

Total 2446 results

Hospital Israelita Albert Einstein
CytoDyn, Inc.

Suspended

Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia

COVID-19 Pneumonia

Brazil
Canadian Immunodeficiency Research Collaborative
Hoffmann-La Roche

Completed

Fuzeon Viral Decay Pilot Study

HIV-1

Canada
GlaxoSmithKline

Terminated

Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

HIV Infection

United States, Germany, Belgium, Canada, Denmark
PENTA Foundation
ViiV Healthcare; Hospital Universitario 12 de Octubre; Cromsource; PHPT Foundation

Recruiting

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

HIV Infections With Multi Drug Resistant Virus

United States, South Africa, Mexico, Spain
Hospital Israelita Albert Einstein
CytoDyn, Inc.

Suspended

Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation

COVID-19 Pneumonia

Brazil
ViiV Healthcare
GlaxoSmithKline

Completed

Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
Drexel University
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

PRO 140 for Human Immunodeficiency Virus Infection

HIV

United States
Hoffmann-La Roche

Completed

A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection

HIV Infections

Thailand
GlaxoSmithKline

Terminated

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

HIV Infection

Germany
National Institute of Allergy and Infectious Diseases...

Completed

GW873140 to Treat HIV-1 Infected Adults

HIV Infections

United States
Fundación Huésped
Pfizer

Unknown

Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients (TERCETO)

AIDS | HIV-1 Adults Patients | Triple Class Failure

Argentina
Taichung Veterans General Hospital
GlaxoSmithKline

Terminated

Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation (NUC115132)

Chronic Hepatitis B

Taiwan
Avazzia, Inc
Joseph Surace, D.C.

Active, not recruiting

Avazzia HVPC Bio-Electrical Stimulation Technology (BEST™) Microcurrent CTS RCT

Carpal Tunnel Syndrome

United States
Tibotec Pharmaceuticals, Ireland

Completed

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

Human Immunodeficiency Virus Type 1
Hoffmann-La Roche
Roche Molecular Systems, Inc

Not yet recruiting

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

Chlamydia Trachomatis Infection | Mycoplasma Genitalium Infection | Neisseria Gonorrhoeae Infection
Masonic Cancer Center, University of Minnesota
Susan G. Komen Breast Cancer Foundation

Completed

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Breast Cancer

United States
Milton S. Hershey Medical Center
Penn State University

Terminated

Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women

Smoking | Smoking Cessation | Pregnancy

United States
Hoffmann-La Roche

Completed

A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection

HIV Infections

Bulgaria
Hoffmann-La Roche
Trimeris

Completed

BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection

HIV Infections

United States, Puerto Rico
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Active, not recruiting

Alignment of PrEP Use With HIV Risk in Young Women and Men

HIV Infections | Sexually Transmitted Diseases, Bacterial | Pre-Exposure Prophylaxis

Uganda
ViiV Healthcare
GlaxoSmithKline

Completed

Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529

Infection, Human Immunodeficiency Virus

United States
Tel-Aviv Sourasky Medical Center
Hadassah Medical Organization; Soroka University Medical Center

Recruiting

Safety and Efficacy of Maraviroc in Post-stroke Cognitive Impairment

Post Stroke Cognitive Impairment

Israel
CytoDyn, Inc.

No longer available

A Compassionate Use Study of Leronlimab in Breast Cancer

Metastatic Triple-Negative Breast Carcinoma
CytoDyn, Inc.

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019

United States
Imperial College London
Pfizer

Completed

The Maraviroc Central Nervous System (CNS) Study

HIV Infections

United Kingdom
University of Iowa
Holden Comprehensive Cancer Center

Completed

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

Head and Neck Neoplasms | Carcinoma, Adenoid Cystic

United States
University of Wisconsin, Madison
Agouron Pharmaceuticals

Completed

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection

HIV Infections

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet

Infection, Human Immunodeficiency Virus

United Kingdom
Hoffmann-La Roche
Trimeris

Completed

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

HIV Infections

United States
Rockefeller University
Pfizer; Aaron Diamond AIDS Research Center

Completed

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

HIV Infections

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet

Pharmacokinetics
Mayo Clinic

Completed

Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults

Immune Response

United States
Technical University of Munich
Gilead Sciences; MUC Research GmbH

Completed

Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication

Insulin Resistance

Germany
Humanity and Health Research Centre
Beijing 302 Hospital; Nanfang Hospital of Southern Medical University

Completed

DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) (DASCO)

Chronic Hepatitis C Infection | Hepatitis B Reactivation | HBV Coinfection

China
NGO Via Libre
University of Washington

Completed

Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru

HIV Infections

Peru
Adocia

Completed

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Rhode Island Hospital

Completed

Maraviroc in Patients With Moderate and Severe COVID-19

COVID

United States
ViiV Healthcare

Active, not recruiting

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

HIV Infections

United States, Spain, France, Australia, Germany, Belgium, Canada, Argentina, Brazil, Italy, Romania, Mexico, Taiwan, Netherlands, South Africa, Russian Federation, Greece, Portugal, United Kingdom, Poland, Peru, Chile, Colombia, Ireland and more
ViiV Healthcare
GlaxoSmithKline

Completed

Fosamprenavir Versus Other Protease Inhibitors

Infection, Human Immunodeficiency Virus I

United States, Puerto Rico
CytoDyn, Inc.

Withdrawn

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

HIV

United States
ViiV Healthcare
Pfizer

Completed

Multicenter, Safety Study Of Maraviroc

Acquired Immunodeficiency Syndrome | HIV Infection

Brazil
Hospital Clinic of Barcelona

Unknown

Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3 (DIS-MVC)

HIV-1 Infection

Spain
Hospital Clinic of Barcelona
Hoffmann-La Roche

Completed

Metabolic Effects of Enfuvirtide in Healthy Volunteers

HIV Infections

Spain
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
University Hospital, Ghent

Completed

The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate. (DNAFRAG)

Unexplained Infertility

Belgium
CytoDyn, Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140 (PRO140)

HIV

United States, Puerto Rico
Shanghai Zerun Biotechnology Co.,Ltd
Walvax Biotechnology Co., Ltd.

Active, not recruiting

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Cervical Cancer | Papillomavirus Infections | CIN | Genital Wart | VIN

China
National Institute of Allergy and Infectious Diseases...

Completed

Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection

HIV Infections

United States
Lille Catholic University

Completed

Effects of the Humanitude® Care Methodology on Health Professionals' Perception (Humanitude)

Education, Medical | Caregiver | Delivery of Health Care

France
AbbVie (prior sponsor, Abbott)

Completed

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Human Immunodeficiency Virus Infection

Search clinical trials for: Xpert® HCV Viral test

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations